Atlas Trials

A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

Clinical trial NCT06041022 · UNKNOWN

Trial details

NCT number
NCT06041022
Sponsor
Qilu Hospital of Shandong University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatitis B, Chronic
Start date
2023-10-01
Primary completion
2023-11-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.